Revotaz 4000 mg/500 mg Injection
By Revotaz
Rx
1gm Injection in a Vial

Composition
Piperacillin(4000mg) + Tazobactum(500mg)

Manufacturer - Alkem Laboratories Ltd
Alkem Laboratories Limited, Devashish Building, Alkem House, Senapati Bapat Road, Lower Parel, Mumbai - 400 013.

Expires on or after
June, 2026

liver
Revotaz 4000 mg/500 mg Injection is considered safe for use in patients with liver disease. The available data indicates that adjusting the dose of Revotaz 4000 mg/500 mg Injection may not be necessary for these patients. It is important to consult your doctor regarding the use of this injection to ensure proper guidance.

kidney
Revotaz 4000 mg/500 mg Injection requires caution in kidney disease patients. Adjusting the dosage may be necessary. Consult your doctor before use.

alcohol
When taking Revotaz 4000 mg/500 mg Injection, it is safe to consume alcohol as no harmful side effects have been reported.

driving
When using Revotaz 4000 mg/500 mg Injection, it is uncertain if driving ability is affected. Avoid driving if experiencing symptoms that impact concentration and reaction time.

pregnancy
Revotaz 4000 mg/500 mg Injection is generally safe to use during pregnancy based on animal studies with minimal adverse effects. Limited human studies are available.

breastfeeding
Revotaz 4000 mg/500 mg Injection is considered safe for use during breastfeeding based on human studies. The drug does not pass into breastmilk in a significant amount, posing no harm to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI INFECTIVES |
Action Class | - |
₹446.94
Inclusive of all taxes
Content verified by

Dr. Monie Riju Simon
MBBS - General Medicine
Last update on 18-Nov-2024